NEW YORK, on Dec 14 , said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.

The post Pfizer says COVID-19 pill near 90% effective in final analysis appeared first on NewsDay Zimbabwe.